Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir

AIDS. 1998 Oct 22;12(15):2080-2. doi: 10.1097/00002030-199815000-00025.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / blood
  • Anti-HIV Agents / pharmacokinetics
  • Anti-HIV Agents / therapeutic use
  • Chromatography, High Pressure Liquid
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / therapeutic use
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / blood
  • HIV Protease Inhibitors / pharmacokinetics*
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Indinavir / blood
  • Indinavir / pharmacokinetics*
  • Indinavir / therapeutic use
  • Omeprazole / pharmacokinetics*
  • Omeprazole / therapeutic use
  • Proton Pump Inhibitors

Substances

  • Anti-HIV Agents
  • Enzyme Inhibitors
  • HIV Protease Inhibitors
  • Proton Pump Inhibitors
  • Indinavir
  • Omeprazole